881 / 1481
• Adjuvant if ECE or T3
• Early if rising PSA ≥ 0.2 ng/ml
• Consider neo-adjuvant hormone therapy
• Cover SV region if involved or elements of SV remaining
• Value of adjuvant pelvic nodes coverage remains uncertain
Take Home Message